Perspectives on mirabegron in the treatment of overactive bladder syndrome: A new beta-3 adrenoceptor agonist

Perspectives on mirabegron in the treatment of overactive bladder syndrome: A new beta-3 adrenoceptor agonist

Mirabegron, the first β3-adrenoceptor agonist introduced for use in clinical practice, differs from antimuscarinic agents in terms of mechanism of action. This review discusses various perspectives on mirabegron in terms of efficacy, mechanism of action, pharmacokinetics, safety, and tolerability fo...

Full description

Bibliographic Details
Main Authors:	Chia-Hao Kuei, Chung-Hsin Peng, Chun-Hou Liao
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2015-03-01
Series:	Urological Science
Subjects:	beta-adrenoceptor agonist overactive bladder
Online Access:	http://www.sciencedirect.com/science/article/pii/S1879522614001213

Similar Items

Mirabegron, a breakthrough in overactive bladder syndrome?
by: Almudena Maestro Nombela, et al.
Published: (2017-05-01)

Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?
by: Ömer Acar, et al.
Published: (2019-06-01)

Mirabegron: A first-in-class beta-3 agonist for overactive bladder
by: Suruchi Aditya, et al.
Published: (2015-01-01)

THE EFFICACY COMPARISON OF MIRABEGRON AS A MONOTHERAPY VERSUS ITS COMBINATION WITH SOLIFENACIN IN OVERACTIVE BLADDER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
by: Hasan Madani, et al.
Published: (2021-07-01)

Mirabegron for Overactive Bladder: A Novel, First-in-Class β3- Agonist Therapy
by: Mohammed Imran, et al.
Published: (2013-09-01)

Ocular and Systemic Safety of Mirabegron Treatment in Elderly People with Overactive Bladder
by: Mehmet Solakhan, et al.
Published: (2019-09-01)

Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials
by: Hann-Chorng Kuo, et al.
Published: (2015-03-01)

Mirabegron: the review of current knowledge of safety and efficacy in the relief of overactive bladder symptoms
by: Tomasz Aleksiewicz, et al.
Published: (2018-08-01)

The impact of Mirabegron on sexual function in women with idiopathic overactive bladder
by: Marilena Gubbiotti, et al.
Published: (2019-01-01)

Profile of mirabegron in the treatment of overactive bladder: place in therapy
by: Sharaf A, et al.
Published: (2017-02-01)

First Direct Isolation of Stable α-Form Crystals of Mirabegron, a Selective β3–Adrenoceptor Agonist
by: Vijayavitthal T. Mathad, et al.
Published: (2017-06-01)

Overactive bladder – 18 years – Part II
by: Jose Carlos Truzzi, et al.
Published: (2016-04-01)

Overactive bladder – 18 years – part I
by: Jose Carlos Truzzi, et al.
Published: (2016-04-01)

Efficacy and tolerability of mirabegron compared with solifenacin for children with idiopathic overactive bladder: A preliminary study
by: Seong Cheol Kim, et al.
Published: (2021-05-01)

Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient
by: Makhani A, et al.
Published: (2020-04-01)

MODERN POSSIBILITIES OF MEDICAL TREATMENT OF OVERACTIVE BLADDER IN WOMEN
by: I. A. Apolikhina, et al.
Published: (2017-12-01)

A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain
by: Jameel Nazir, et al.
Published: (2018-09-01)

The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study
by: A. Zachariou, et al.
Published: (2018-06-01)

Meta-Analysis of the Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin for Overactive Bladder
by: Yankai Xu, et al.
Published: (2017-09-01)

The Effect of Polymorphisms of Beta2 Adrenoceptors on Response to Long-acting Beta2 Agonists in Iranian Asthmatic Patients
by: Fatemeh Soleimani, et al.
Published: (2013-12-01)

Medical management of overactive bladder
by: Sarvpreet S Ubee, et al.
Published: (2010-01-01)

Investigation of the reasons for withdrawal from long-term treatment with mirabegron of treatment-naïve Japanese female patients with overactive bladder in the real-world clinical setting
by: Yoshinori Tanaka, et al.
Published: (2019-01-01)

Efficacy of adding mirabegron to alpha-adrenoreceptor blocker in patients with benign prostatic hyperplasia with persistent overactive bladder symptoms: A prospective study
by: Se Yun Kwon, et al.
Published: (2020-07-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Additional low-dose antimuscarinics can improve overactive bladder symptoms in patients with suboptimal response to beta 3 agonist monotherapy
by: Jung Hyun Shin, et al.
Published: (2017-07-01)

A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors
by: Andrzej Wróbel, et al.
Published: (2020-03-01)

Postmenopausal overactive bladder
by: Jacek Tomaszewski
Published: (2014-12-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

Overactive bladder
by: Anna Zwierzyńska
Published: (2021-07-01)

ONABOTULINUM TOXIN-A FOR OVERACTIVE BLADDER
by: Mahmood Shakir Abdulkarim
Published: (2016-12-01)

Clustering of patients with overactive bladder syndrome
by: James Gross, et al.
Published: (2021-03-01)

Effect of caffeine on bladder function in patients with overactive bladder symptoms
by: Supatra Lohsiriwat, et al.
Published: (2011-01-01)

Cerebellar Ataxia and Overactive Bladder after Encephalitis Affecting the Cerebellum
by: Megumi Sugiyama, et al.
Published: (2009-07-01)

Clinical Experience of the Use of Tolterodine in Patients with Overactive Bladder at Siriraj Hospital
by: Vitaya Titapant, et al.
Published: (2020-08-01)

Development and validation of the Chinese Overactive Bladder Symptom Score for assessing overactive bladder syndrome in a RESORT study
by: Man-Jung Hung, et al.
Published: (2013-05-01)

Efficacy and tolerability of mirabegron in female patients with overactive bladder symptoms after surgical treatment for stress urinary incontinence
by: Mete Özkidik, et al.

Effect of Mirabegron on Intraocular Pressure in Patients with Glaucoma
by: Emine Şeker Ün, et al.
Published: (2020-06-01)

Impact of overactive bladder on retrograde ejaculation
by: Ahmet Salvarci, et al.

The surgical management of the refractory overactive bladder
by: Nikhil Vasdev, et al.
Published: (2010-01-01)

Electroacupuncture to treat with Overactive Bladder in Postmenopausal Women: study protocol for a multicenter, randomized, controlled, parallel clinical trial
by: Eun-Young Nam, et al.
Published: (2018-09-01)